Imatinib Completed Phase 1 Trials for Chronic Myeloid Leukemia (CML) / Gastrointestinal Stromal Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00040105Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
NCT01270984Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects
NCT01751919A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)
NCT01795716Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body
NCT00428909Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
NCT00135005Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
NCT00441155Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib